Skip to content

Comparison of triamcinolone and dextrose prolotherapy in patients with knee osteoarthritis

The effect of intra articular injection of triamcinolone in comparison with dextrose prolotherapy on pain and function of patients with knee osteoarthritis, single blind clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170311033000N4
Enrollment
40
Registered
2020-04-23
Start date
2019-01-30
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. M17

Interventions

Intervention 1: Intervention group: Intervention group 1: triamcinolone, knee intraarticular injection, 40 mg 1 time. Intervention 2: Intervention group: Single dextrose prolotherapy as an intra-artic

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: arthralgia since the past 3 months; radiologic evidence of articular damage (grade 2,3 of Kellgren-Lawrence scale) based on knee OA criteria of ACR and age between 45-75 years.

Exclusion criteria

Exclusion criteria: Exclusion criteria: systemic diseases such as rheumatoid arthritis (RA), any history of intera articular injection, knee surgery or physiotherapy in the last 3 months.

Design outcomes

Primary

MeasureTime frame
Knee pain. Timepoint: Before intervention,1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;Joint Stiffness. Timepoint: Before intervention, 1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: Before intervention, 1 months & 3 months after intervention. Method of measurement: WOMAC questionnaire.;The maximum distance of walking. Timepoint: ????Before intervention, 1 months & 3 months after intervention. Method of measurement: Lequesne Index.;Activity of daily living. Timepoint: ????Before intervention, 1 months & 3 months after intervention. Method of measurement: Lequesne Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Modabberi

Shahid Beheshti University of Medical Sciences

mohsen_modabberi@yahoo.com0098113204024

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026